Evaluation the effects of camel milk on treatment of children with Cystic Fibrosis
Phase 3
Recruiting
- Conditions
- Cystic Fibrosis lung disease in children.Cystic fibrosis
- Registration Number
- IRCT20210914052477N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Over 6 year’s children with Cystic Fibrosis lung disease undergoing airway Clearance Treatment
The patient is not in the acute exacerbation phase of the disease
The patient has completed the Informed consent Form
Those who have FEV1 more than 60% in spirometry
Exclusion Criteria
Those who are allergic to cow's milk
Those who have a severe cough and sputum
Those who are hospitalized
Those who do not cooperate properly in spirometry
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients with Expiratory Volume in First Second (FEV1) greater than 60%. Timepoint: At the beginning of the study (before the intervention) and two months after beginning milk use (after the intervention). Method of measurement: spirometer device.
- Secondary Outcome Measures
Name Time Method Percentage of patient whose Forced Expiratory Volume in First Second (FEV1) increase 10%. Timepoint: At the beginning of the study (before the intervention) and two months after beginning milk use (after the intervention). Method of measurement: spirometer device.